Congenital transmission of Chagas disease: a clinical approach

References

• Pays JF. Chagas Carlos Justiniano Ribeiro (1879–1934). Bull. Soc. Pathol. Exot.102(5), 276–279 (2009).
   PubMedGoogle Scholar
• Voelker R. A century after Chagas disease discovery, hurdles to tackling the infection remain. JAMA302(10), 1045–1047 (2009).
   PubMedGoogle Scholar
• Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol.22(12), 583–588 (2006).
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Segura EL. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr. Opin. Infect. Dis.19(6), 583–587 (2006).
   PubMed Web of Science ®Google Scholar
• Coura JR. Chagas disease: what is known and what is needed – a background article. Mem. Inst. Oswaldo Cruz102(Suppl. 1), 113–122 (2007).
   PubMed Web of Science ®Google Scholar
• Reithinger R, Tarleton RL, Urbina JA, Kitron U, Gurtler RE. Eliminating Chagas disease: challenges and a roadmap. Br. Med. J.338, b1283 (2009).
   PubMedGoogle Scholar
• Wanderley DM, de Carvalho ME, Mantegazza E, Yasumaru S, Barata LC. Transfusional Chagas infection detected in the program for the control of Chagas disease in the state of Sao Paulo (Brazil). Rev. Saude Publica26(3), 203–205 (1992).
   PubMedGoogle Scholar
• Kun H, Moore A, Mascola L et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin. Infect. Dis.48(11), 1534–1540 (2009).
   PubMed Web of Science ®Google Scholar
• Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop.115(1–2), 14–21 (2010).
   PubMed Web of Science ®Google Scholar
• Pereira KS, Schmidt FL, Guaraldo AM et al. Chagas’ disease as a foodborne illness. J. Food Prot.72(2), 441–446 (2009).
   PubMed Web of Science ®Google Scholar
• Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem. Inst. Oswaldo Cruz104(Suppl. 1), 101–107 (2009).
   PubMedGoogle Scholar
• Beltrao Hde B, Cerroni Mde P, Freitas DR et al. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007. Trop. Doct.39(4), 231–232 (2009).
   PubMedGoogle Scholar
• Valente SA, da Costa Valente V, das Neves Pinto AY et al. Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Trans. R. Soc. Trop. Med. Hyg.103(3), 291–297 (2009).
   PubMed Web of Science ®Google Scholar
• Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev.14(4), 659–688 (2001).
   PubMed Web of Science ®Google Scholar
• WHO. Chagas disease: control and elimination. Report by the Secretariat. In: Sixty-Second World Health Assembly. Provisional Agenda Item 12.12. A62/17.20 (2009).
   Google Scholar
• Okumura M, Aparecida dos Santos V, Camargo ME, Schultz R, Zugaib M. Prenatal diagnosis of congenital Chagas’ disease (American trypanosomiasis). Prenat. Diagn.24(3), 179–181 (2004).
   PubMed Web of Science ®Google Scholar
• Gurtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg. Infect. Dis.9(1), 29–32 (2003).
   PubMed Web of Science ®Google Scholar
• Jackson Y, Myers C, Diana A et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg. Infect. Dis.15(4), 601–603 (2009).
   PubMed Web of Science ®Google Scholar
• Munoz J, Gomez i Prat J, Gallego M et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop.111(1), 51–55 (2009).
   PubMed Web of Science ®Google Scholar
• Muñoz J, Portus M, Corachan M, Fumado V, Gascon J. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans. R. Soc. Trop. Med. Hyg.101(11), 1161–1162 (2007).
   PubMed Web of Science ®Google Scholar
• Riera C, Guarro A, Kassab HE et al. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am. J. Trop. Med. Hyg.75(6), 1078–1081 (2006).
   PubMedGoogle Scholar
• Piron M, Verges M, Munoz J et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion48(9), 1862–1868 (2008).
   PubMed Web of Science ®Google Scholar
• Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J. Infect. Dis.198(4), 609–613 (2008).
   PubMedGoogle Scholar
• Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop.115(1–2), 22–27 (2010).
   PubMed Web of Science ®Google Scholar
• Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL. Chagas disease and the US blood supply. Curr. Opin. Infect. Dis.21(5), 476–482 (2008).
   PubMedGoogle Scholar
• Castro E. Chagas’ disease: lessons from routine donation testing. Transfus. Med.19(1), 16–23 (2009).
   PubMedGoogle Scholar
• Yamagata Y, Nakagawa J. Control of Chagas disease. Adv. Parasitol.61, 129–165 (2006).
   PubMed Web of Science ®Google Scholar
• Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin. Microbiol. Rev.18(1), 12–29 (2005).
   PubMed Web of Science ®Google Scholar
• Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem. Inst. Oswaldo Cruz104(Suppl. 1), 17–30 (2009).
   PubMed Web of Science ®Google Scholar
• Guhl F, Pinto N, Aguilera G. Sylvatic triatominae: a new challenge in vector control transmission. Mem. Inst. Oswaldo Cruz104(Suppl. 1), 71–75 (2009).
   PubMedGoogle Scholar
• Massad E. The elimination of Chagas’ disease from Brazil. Epidemiol. Infect.136(9), 1153–1164 (2008).
   PubMed Web of Science ®Google Scholar
• Uruguay declared free of Chagas disease transmission. TDR News56, 6 (1998).
   Google Scholar
• Dias JC. Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem. Inst. Oswaldo Cruz102(Suppl. 1), 11–18 (2007).
   PubMed Web of Science ®Google Scholar
• Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gurtler RE. The challenges of Chagas disease – grim outlook or glimmer of hope. PLoS Med.4(12), e332 (2007).
   PubMed Web of Science ®Google Scholar
• Chippaux JP, Santalla JA, Postigo JR et al. Sensitivity and specificity of Chagas Stat-Pak test in Bolivia. Trop. Med. Int. Health14(7), 732–735 (2009).
   PubMedGoogle Scholar
• Sosa-Estani S, Gamboa-Leon MR, Del Cid-Lemus J et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am. J. Trop. Med. Hyg.79(5), 755–759 (2008).
   PubMed Web of Science ®Google Scholar
• Russomando G, de Tomassone MM, de Guillen I et al. Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am. J. Trop. Med. Hyg.59(3), 487–491 (1998).
   PubMed Web of Science ®Google Scholar
• Russomando G, Almiron M, Candia N et al. Implementation and evaluation of a locally sustainable system of prenatal diagnosis to detect cases of congenital Chagas disease in endemic areas of Paraguay. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 49–54 (2005).
   PubMed Web of Science ®Google Scholar
• Torrico F, Alonso-Vega C, Suarez E et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am. J. Trop. Med. Hyg.70(2), 201–209 (2004).
   PubMed Web of Science ®Google Scholar
• Salas NA, Cot M, Schneider D et al. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop. Med. Int. Health12(12), 1498–1505 (2007).
   PubMedGoogle Scholar
• Brutus L, Schneider D, Postigo J et al. Congenital Chagas disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop.106(3), 195–199 (2008).
   PubMedGoogle Scholar
• Blanco SB, Segura EL, Cura EN et al. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop. Med. Int. Health5(4), 293–301 (2000).
   PubMed Web of Science ®Google Scholar
• Reiche EM, Morimoto HK, Farias GN et al. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C, human immunodeficiency virus infection, assayed through serological tests among pregnant patients, from 1996 to 1998, at the Regional University Hospital Norte do Parana. Rev. Soc. Bras. Med. Trop.33(6), 519–527 (2000).
   PubMedGoogle Scholar
• Mendoza Ticona CA, Cordova Benzaquen E, Ancca Juarez J et al. The prevalence of Chagas’ disease in puerperal women and congenital transmission in an endemic area of Peru. Rev. Panam. Salud Publica17(3), 147–153 (2005).
   PubMedGoogle Scholar
• Garcia A, Bahamonde M, Verdugo S et al.Trypanosoma cruzi transplacental infection: situation in Chile. Rev. Med. Chil.129(3), 330–332 (2001).
   PubMedGoogle Scholar
• Brutus L, Schneider D, Postigo J et al. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans. R. Soc. Trop. Med. Hyg.101(11), 1159–1160 (2007).
   PubMedGoogle Scholar
• Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP. Screening for congenital infection by Trypanosoma cruzi in France. Bull. Soc. Pathol. Exot.102(5), 300–309 (2009).
   PubMedGoogle Scholar
• Muñoz J, Coll O, Juncosa T et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin. Infect. Dis.48(12), 1736–1740 (2009).
   PubMed Web of Science ®Google Scholar
• Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz102(Suppl. 1), 75–85 (2007).
   PubMed Web of Science ®Google Scholar
• Di Pentima MC, Hwang LY, Skeeter CM, Edwards MS. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin. Infect. Dis.28(6), 1281–1285 (1999).
   PubMedGoogle Scholar
• Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI et al. Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community. Enferm. Infecc. Microbiol. Clin.26(10), 609–613 (2008).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, Gonzalez-Tome MI. Chagas disease travels to Europe. Lancet373(9680), 2025 (2009).
   PubMedGoogle Scholar
• Hernandez-Matheson IM, Frankowski RF, Held B. Foeto-maternal morbidity in the presence of antibodies to Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg.77(3), 405–411 (1983).
   PubMedGoogle Scholar
• Schenone H, Contreras MC, Borgono JM, Rojas A, Villarroel F. Congenital Chagas’ disease in Chile. Longitudinal study of the reproductivity of women with or without Chagas’ disease and of some parasitological and clinical parameters of them and their corresponding children. Bol. Chil. Parasitol.40(1–2), 24–29 (1985).
   PubMedGoogle Scholar
• Bittencourt AL. Possible risk factors for vertical transmission of Chagas’ disease. Rev. Inst. Med. Trop. Sao Paulo34(5), 403–408 (1992).
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Garcia AG. The placenta in hematogenous infections. Pediatr. Pathol. Mol. Med.21(4), 401–432 (2002).
   PubMedGoogle Scholar
• Hermann E, Truyens C, Alonso-Vega C et al. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon-γ in response to parasite antigens. J. Infect. Dis.189(7), 1274–1281 (2004).
   PubMed Web of Science ®Google Scholar
• Yadon ZE, Schmunis GA. Congenital Chagas disease: estimating the potential risk in the United States. Am. J. Trop. Med. Hyg.81(6), 927–933 (2009).
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Dri L, Touris C et al. Vectorial and congenital transmission of Trypanosoma cruzi in Las Lomitas, Formosa. Medicina (B. Aires)69(4), 424–430 (2009).
   PubMedGoogle Scholar
• Pan American Health Organization (PAHO). Organización Panamericana de la Salud. Estimación cuantitativa de la Enfermedad de Chagas en las Ameritas (2006).
   Google Scholar
• Di Pentima MC, Edwards MS. Enzyme-linked immunosorbent assay for IgA antibodies to Trypanosoma cruzi in congenital infection. Am. J. Trop. Med. Hyg.60(2), 211–214 (1999).
   PubMedGoogle Scholar
• Pehrson PO, Wahlgren M, Bengtsson E. Asymptomatic congenital Chagas’ disease in a 5-year-old child. Scand. J. Infect. Dis.13(4), 307–308 (1981).
   PubMed Web of Science ®Google Scholar
• Flores-Chavez M, Faez Y, Olalla JM et al. Fatal congenital Chagas’ disease in a non-endemic area: a case report. Cases J.1(1), 302 (2008).
   PubMedGoogle Scholar
• Carrilero B, Quesada JJ, Alfayate S, Segovia M. Congenital Chagas disease in a newborn of a Bolivian mother. Enferm. Infecc. Microbiol. Clin.27(8), 486–487 (2009).
   PubMedGoogle Scholar
• WHO. Control of Chagas disease. World Health Organ. Tech. Rep. Ser.905, i–vi, 1–109, back cover (2002).
   PubMedGoogle Scholar
• Castro C, Prata A, Macedo V. The influence of the parasitemia on the evolution of the chronic Chagas’ disease. Rev. Soc. Bras. Med. Trop.38(1), 1–6 (2005).
   PubMedGoogle Scholar
• Garcia MM, De Rissio AM, Villalonga X, Mengoni E, Cardoni RL. Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children. Am. J. Trop. Med. Hyg.78(3), 499–503 (2008).
   PubMed Web of Science ®Google Scholar
• Cardoni RL, Garcia MM, De Rissio AM. Proinflammatory and anti-inflammatory cytokines in pregnant women chronically infected with Trypanosoma cruzi. Acta Trop.90(1), 65–72 (2004).
   PubMedGoogle Scholar
• Bern C, Verastegui M, Gilman RH et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin. Infect. Dis.49(11), 1667–1674 (2009).
   PubMed Web of Science ®Google Scholar
• Bern C, Montgomery SP, Herwaldt BL et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA298(18), 2171–2181 (2007).
   PubMed Web of Science ®Google Scholar
• Torrico F, Vega CA, Suarez E et al. Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop. Med. Int. Health11(5), 628–635 (2006).
   PubMedGoogle Scholar
• Moretti E, Basso B, Castro I et al. Chagas’ disease: study of congenital transmission in cases of acute maternal infection. Rev. Soc. Bras. Med. Trop.38(1), 53–55 (2005).
   PubMed Web of Science ®Google Scholar
• Triquell MF, Diaz-Lujan C, Freilij H, Paglini P, Fretes RE. Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction. Trans. R. Soc. Trop. Med. Hyg.103(10), 1011–1018 (2009).
   PubMed Web of Science ®Google Scholar
• Zingales B, Andrade SG, Briones MR et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz104(7), 1051–1054 (2009).
   PubMed Web of Science ®Google Scholar
• Macedo AM, Machado CR, Oliveira RP, Pena SD. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem. Inst. Oswaldo Cruz99(1), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Vago AR, Andrade LO, Leite AA et al. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol.156(5), 1805–1809 (2000).
   PubMed Web of Science ®Google Scholar
• Burgos JM, Altcheh J, Bisio M et al. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. Int. J. Parasitol.37(12), 1319–1327 (2007).
   PubMed Web of Science ®Google Scholar
• Freitas JM, Andrade LO, Pires SF et al. The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains. PLoS One4(4), e5113 (2009).
   PubMedGoogle Scholar
• Miles MA, Feliciangeli MD, de Arias AR. American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. Br. Med. J.326(7404), 1444–1448 (2003).
   PubMedGoogle Scholar
• Rivero A. Nitric oxide: an antiparasitic molecule of invertebrates. Trends Parasitol.22(5), 219–225 (2006).
   PubMedGoogle Scholar
• Orange SJ, Painter D, Horvath J et al. Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin. Exp. Pharmacol. Physiol.30(5–6), 376–381 (2003).
   PubMed Web of Science ®Google Scholar
• Corrales RM, Mora MC, Negrette OS et al. Congenital Chagas disease involves Trypanosoma cruzi sub-lineage IId in the northwestern province of Salta, Argentina. Infect. Genet. Evol.9(2), 278–282 (2009).
   PubMed Web of Science ®Google Scholar
• Virreira M, Truyens C, Alonso-Vega C et al. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am. J. Trop. Med. Hyg.77(1), 102–106 (2007).
   PubMed Web of Science ®Google Scholar
• Shippey SH 3rd, Zahn CM, Cisar MM, Wu TJ, Satin AJ. Use of the placental perfusion model to evaluate transplacental passage of Trypanosoma cruzi. Am. J. Obstet. Gynecol.192(2), 586–591 (2005).
   PubMed Web of Science ®Google Scholar
• Fernandez-Aguilar S, Lambot MA, Torrico F et al. Placental lesions in human Trypanosoma cruzi infection. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 84–86 (2005).
   PubMedGoogle Scholar
• Altemani AM, Bittencourt AL, Lana AM. Immunohistochemical characterization of the inflammatory infiltrate in placental Chagas’ disease: a qualitative and quantitative analysis. Am. J. Trop. Med. Hyg.62(2), 319–324 (2000).
   PubMedGoogle Scholar
• Teixeira AR, Nascimento RJ, Sturm NR. Evolution and pathology in chagas disease – a review. Mem. Inst. Oswaldo Cruz101(5), 463–491 (2006).
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Garcia AG. Pathogenesis and pathology of hematogenous infections of the fetus and newborn. Pediatr. Pathol. Mol. Med.21(4), 353–399 (2002).
   PubMedGoogle Scholar
• Padilla AM, Bustamante JM, Tarleton RL. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol.21(4), 385–390 (2009).
   PubMed Web of Science ®Google Scholar
• Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop.36(6), 767–771 (2003).
   PubMedGoogle Scholar
• Freilij H, Altcheh J. Congenital Chagas’ disease: diagnostic and clinical aspects. Clin. Infect. Dis.21(3), 551–555 (1995).
   PubMed Web of Science ®Google Scholar
• Altcheh J, Biancardi M, Lapena A, Ballering G, Freilij H. Congenital Chagas disease: experience in the Hospital de Ninos, Ricardo Gutierrez, Buenos Aires, Argentina. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 41–45 (2005).
   PubMedGoogle Scholar
• Moya P, Basso B, Moretti E. Congenital Chagas disease in Cordoba, Argentina: epidemiological, clinical, diagnostic, and therapeutic aspects. Experience of 30 years of follow up. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 33–40 (2005).
   PubMedGoogle Scholar
• Shikanai-Yasuda MA, Lopes MH, Tolezano JE et al. Acute Chagas’ disease: transmission routes, clinical aspects and response to specific therapy in diagnosed cases in an urban center. Rev. Inst. Med. Trop. Sao Paulo32(1), 16–27 (1990).
   PubMed Web of Science ®Google Scholar
• Muñoz Casas del Valle P, Thiermann E, Atias M, Acevedo CS. Enfermedad de Chagas congénita sintomática en recién nacidos y lactantes. Rev. Chil. Pediatr.63(4), 196–202 (1992).
   Google Scholar
• Garcia-Bournissen F, Altcheh J, Giglio N et al. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina. Paediatr. Drugs11(1), 33–37 (2009).
   PubMedGoogle Scholar
• Virreira M, Torrico F, Truyens C et al. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg.68(5), 574–582 (2003).
   PubMed Web of Science ®Google Scholar
• Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin. Infect. Dis.49(7), 1103–1108 (2009).
   PubMed Web of Science ®Google Scholar
• Torrico MC, Solano M, Guzman JM et al. Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 58–61 (2005).
   PubMedGoogle Scholar
• Gomes YM, Lorena VM, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem. Inst. Oswaldo Cruz104(Suppl. 1), 115–121 (2009).
   PubMed Web of Science ®Google Scholar
• Britto CC. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem. Inst. Oswaldo Cruz104(Suppl. 1), 122–135 (2009).
   PubMed Web of Science ®Google Scholar
• Piron M, Fisa R, Casamitjana N et al. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop.103(3), 195–200 (2007).
   PubMed Web of Science ®Google Scholar
• Schijman AG, Altcheh J, Burgos JM et al. Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction. J. Antimicrob. Chemother.52(3), 441–449 (2003).
   PubMed Web of Science ®Google Scholar
• Mora MC, Sanchez Negrette O, Marco D et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J. Parasitol.91(6), 1468–1473 (2005).
   PubMedGoogle Scholar
• Chippaux JP, Clavijo AN, Santalla JA et al. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole. Trop. Med. Int. Health15(1), 87–93 (2010).
   PubMed Web of Science ®Google Scholar
• Mallimaci MC, Sosa-Estani S, Russomando G et al. Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina. Am. J. Trop. Med. Hyg.82(1), 55–59 (2010).
   PubMed Web of Science ®Google Scholar
• Breniere SF, Yaksic N, Telleria J et al. Immune response to Trypanosoma cruzi shed acute phase antigen in children from an endemic area for Chagas’ disease in Bolivia. Mem. Inst. Oswaldo Cruz92(4), 503–507 (1997).
   PubMedGoogle Scholar
• Adams ER, Hamilton PB. New molecular tools for the identification of trypanosome species. Future Microbiol.3, 167–176 (2008).
   PubMedGoogle Scholar
• Bittencourt AL, Sadigursky M, Da Silva AA et al. Evaluation of Chagas’ disease transmission through breast-feeding. Mem. Inst. Oswaldo Cruz83(1), 37–39 (1988).
   PubMedGoogle Scholar
• OMS. Reporte sobre la enfermedad de Chagas. Grupo de trabajo científico 17–20 de abril de 2005 – Actualizado en julio de 2007. Buenos Aires, Argentina (2005).
   Google Scholar
• Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem. Inst. Oswaldo Cruz104(Suppl. 1), 319–324 (2009).
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B et al. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev. Anti Infect. Ther.7(2), 157–163 (2009).
   PubMed Web of Science ®Google Scholar
• Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious diseases. Emerg. Infect. Dis.10(6), 1068–1073 (2004).
   PubMedGoogle Scholar
• de Andrade AL, Zicker F, de Oliveira RM et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet348(9039), 1407–1413 (1996).
   PubMed Web of Science ®Google Scholar
• Sosa Estani S, Segura EL, Ruiz AM et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease. Am. J. Trop. Med. Hyg.59(4), 526–529 (1998).
   PubMed Web of Science ®Google Scholar
• Yun O, Lima MA, Ellman T et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Frontieres. PLoS Negl. Trop. Dis.3(7), e488 (2009).
   PubMed Web of Science ®Google Scholar
• Rodrigues Coura J. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem. Inst. Oswaldo Cruz104(4), 549–554 (2009).
   PubMedGoogle Scholar
• Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz97(1), 3–24 (2002).
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Belizan JM, Althabe F, Rubinstein A. The need of a neonatal preparation for Chagas disease. PLoS Med.2(11), e387 (2005).
   PubMedGoogle Scholar
• Ribeiro I, Sevcsik AM, Alves F et al. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl. Trop. Dis.3(7), e484 (2009).
   PubMed Web of Science ®Google Scholar
• Lamas MC, Villaggi L, Nocito I et al. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int. J. Pharm.307(2), 239–243 (2006).
   PubMedGoogle Scholar
• Urbina JA. Chemotherapy of Chagas disease. Curr. Pharm. Des.8(4), 287–295 (2002).
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev. Soc. Bras. Med. Trop.42(5), 484–487 (2009).
   PubMed Web of Science ®Google Scholar
• Suarez E, Alonso-Vega C, Torrico F, Cordova M. Integral treatment of congenital Chagas disease: the Bolivian experience. Rev. Soc. Bras. Med. Trop.38(Suppl. 2), 21–23 (2005).
   PubMedGoogle Scholar
• Altcheh J, Corral R, Biancardi MA, Freilij H. Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection. Medicina (B. Aires),63(1), 37–40 (2003).
   PubMed Web of Science ®Google Scholar
• Galvao LM, Chiari E, Macedo AM et al. PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J. Clin. Microbiol.41(11), 5066–5070 (2003).
   PubMed Web of Science ®Google Scholar
• Gascon J, Pinazo MJ. Controlling vertical transmission of Trypanosoma cruzi: the biggest challenge for imported disease in Spain. Enferm. Infecc. Microbiol. Clin.26(10), 607–608 (2008).
   PubMedGoogle Scholar